Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
25.00
+0.26 (1.05%)
At close: May 29, 2026, 4:00 PM EDT
24.85
-0.15 (-0.60%)
After-hours: May 29, 2026, 6:34 PM EDT

Pulse Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
68.3280.74118.0444.3761.1428.61
Cash & Short-Term Investments
68.3280.74118.0444.3761.1428.61
Cash Growth
-42.72%-31.60%166.06%-27.44%113.67%39.75%
Accounts Receivable
0.160.27---0.06
Inventory
0.210.14---5.82
Other Current Assets
2.452.281.410.961.012.13
Total Current Assets
71.1383.42119.4545.3362.1536.63
Net Property, Plant & Equipment
6.727.068.328.7810.0211.25
Other Intangible Assets
0.410.581.221.892.553.22
Goodwill
2.792.792.792.792.792.79
Other Long-Term Assets
0.580.690.680.370.370.37
Total Assets
81.6294.54132.4659.1577.8854.25
Accounts Payable
2.762.781.671.841.572.9
Accrued Expenses
5.413.587.033.812.64.39
Short-Term Debt
----0.920.44
Current Portion of Leases
1.631.571.361.060.90.77
Unearned Revenue
-----0.02
Total Current Liabilities
9.87.9210.066.715.988.52
Long-Term Leases
5.535.967.548.099.1410.04
Other Long-Term Liabilities
----65-
Total Long-Term Liabilities
5.535.967.548.0974.1410.04
Total Liabilities
15.3213.8817.614.7980.1318.56
Common Stock
0.070.070.070.0600.03
Additional Paid-in Capital
548.09543.87505.3381.22292.42271.86
Retained Earnings
-481.86-463.28-390.5-336.92-294.71-236.2
Shareholders' Equity
66.380.66114.8644.36-2.2535.69
Total Liabilities & Equity
81.6294.54132.4659.1577.8854.25
Total Debt
7.167.538.99.1410.9611.25
Net Cash (Debt)
61.1673.21109.1435.2250.1817.36
Net Cash Growth
-16.45%-32.93%209.87%-29.81%189.00%90.42%
Net Cash Per Share
0.911.091.870.711.480.62
Book Value
66.380.66114.8644.36-2.2535.69
Book Value Per Share
0.981.201.970.89-0.071.28
Tangible Book Value
63.177.29110.8539.68-7.5929.68
Tangible Book Value Per Share
0.931.151.900.80-0.221.06
SEC Filings: 10-K · 10-Q